Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
10/1999
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/26/1999US5972652 Polynucleotides encoding secreted proteins
10/26/1999US5972351 Polypeptides; method of identifying peptides of an antigen of interest which are capable of recognition by or induction of cytotoxic t lymphocytes; vaccines, immunology
10/21/1999WO1999053039A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052547A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999WO1999052515A2 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
10/21/1999WO1999035156B1 Novel macrolides
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327282A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
10/21/1999CA2323733A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999CN1232464A Substd. N-isothiazolyl-(thio) amides
10/20/1999CN1232388A Antimalarial and anti-babesiosis agent and pharmaceutical compositions contg. same
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/19/1999US5969093 Secreted proteins
10/19/1999US5968987 In lipid-based formulations for oral and injectable use
10/19/1999US5968961 Pharmaceutical compositions of tizoxanide and nitazoxanide
10/19/1999US5968507 Method for removing nits from hair
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051264A2 Leishmania cysteine proteinases
10/14/1999WO1999035157B1 Novel erythromycin derivatives
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948627A2 Glutathionylspermidine synthetase
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0722453B1 Process and antiparasitic intermediates for doramectin
10/13/1999CN1231614A Method of producing active immunity with vaccine conjugate
10/13/1999CN1231613A Vaccine composition against malaria
10/12/1999US5965609 An antitumor agent, antimalaria agent, bactericide treating gram-negative bacteria and active drug treating stroke, traumatic brain injury, chronic neurodegenerative disease, alzheimer's disease or amyotropic lateral schlerosis
10/12/1999US5965143 Leishania gene encoding histone polypeptide haveing protective capacity against leishmaniasis
10/07/1999WO1999050387A1 Vaccination modalities
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/06/1999EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/06/1999EP0946515A1 Parasiticidal pyrazoles
10/06/1999EP0946200A1 Immunization of infants
10/06/1999EP0946099A1 Endoparasiticidal and ectoparasiticidal agents
10/06/1999CN1045431C 15-deoxyspergualin analogs, their preparation method, compositions, intermediate and use in preparation of medicine thereof
10/05/1999US5962659 Anthelmintic milbemycins and avermectins
10/05/1999US5962499 Acaricidal, antiparasitic, insecticidal and anthelmintic agents
09/1999
09/30/1999WO1999048501A1 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
09/30/1999WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999CA2325879A1 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
09/29/1999EP0944719A1 Tryparedoxin peroxidase
09/29/1999EP0944630A1 Xanthines and their therapeutic use
09/29/1999EP0944321A1 Compositions for the systemic control of parasites of warm-blooded animals
09/29/1999CN1230195A Treatment of immune disorders
09/29/1999CN1230188A 25-methylene and 24,25-epoxy marcfortines and paraheroquamides
09/29/1999CN1229647A 1,4-diaryl-3-fluoro-2-butene compounds for protecting animals and humans against attach and infestation by arthropod parasites
09/28/1999US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999US5958709 Processes for identifying compounds that bind to the human Y4 receptor
09/28/1999CA1340771C Ethylated avermectins
09/26/1999CA2264260A1 Polynucleotide molecules encoding neospora proteins
09/23/1999WO1999047506A1 Cyclooctadepsipeptides and their use for combating endoparasites
09/23/1999WO1999047139A1 Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
09/23/1999DE19811559A1 New substituted derivatives of cyclooctadepsipeptide PF1022, useful as parasiticides, especially anthelmintics
09/23/1999CA2323628A1 Cyclooctadepsipeptides and their use for combating endoparasites
09/22/1999EP0943623A1 Cyclic hexapeptide antifungal agents
09/22/1999EP0942998A1 Notch
09/22/1999EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
09/22/1999EP0594743B1 Continuous cell line and vaccine against avian coccidia
09/22/1999CN1229438A Erythromycins and process for their preparation
09/22/1999CN1045204C 10,11-methanodibenzosuberane derivatives, preparation method and composition
09/21/1999US5955492 Carboxylic acid indole inhibitors of chemokines
09/21/1999US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
09/21/1999US5955333 Transferring selectable markers into protozoans or yeast by homologus recombination at specific positions in the genome with the use of a vector; replacement of virulence gene; vacine development
09/21/1999US5955086 Oregano for the treatment of internal parasites and protozoa
09/21/1999CA2179286C Broad spectrum antimicrobial compounds and methods of use
09/16/1999WO1999045935A1 Novel nucleoside analogs and uses in treating disease
09/16/1999WO1999045918A1 Methods and compositions for delivery of taxanes
09/16/1999WO1999033868A3 Human papillomavirus vaccine
09/16/1999CA2322494A1 Novel nucleoside analogs and uses in treating disease
09/16/1999CA2288240A1 Methods and compositions for delivery of taxanes
09/15/1999EP0941998A2 3,6-ketal and enol ether macrolide antibiotics
09/15/1999EP0941991A1 2,4-Bis (4-amidino)phenyl furans as anti-pneumocystis carinii agents
09/15/1999EP0644883B1 Enniatines and enniatine derivates used to control endoparasites
09/15/1999CN1228779A Spirocyclic metalloprotease inhibitors
09/15/1999CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor
09/14/1999US5952500 Nucleoside derivatives
09/14/1999US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33
09/14/1999CA2130664C Antiparasitic agents
09/14/1999CA2118491C Avermectin difluoro derivatives
09/10/1999WO1999045016A2 Novel prodrugs for phosphorus-containing compounds
09/10/1999WO1999044635A1 Enhancement of immunity by intranasal inoculation of il-12
09/10/1999CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12
09/08/1999EP0939650A1 Vaccines
09/08/1999CN1228023A Orally applicable formulation of quinolone or naphthyridone carboxylic acids
09/08/1999CN1228022A Parenteral paclitaxel stable non-toxic formulation
09/07/1999US5948791 Quinoline derivatives for treating malaria
09/02/1999WO1999043348A1 Immunostimulation methods for providing disease protection in poultry
09/02/1999WO1999043337A1 Cyclic peptide antifungal agents
09/02/1999WO1999033488A3 Adjuvanted vaccine formulation
09/02/1999WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
09/02/1999CA2321928A1 Cyclic peptide antifungal agents
09/01/1999EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor
09/01/1999EP0938308A1 Antiparasitic agents
09/01/1999EP0938306A1 ANTIMALARIAL COMPOSITIONS CONTAINING $i(CIS)-FUSED CYCLOPENTENO-1,2,4-TRIOXANE DERIVATIVES
09/01/1999EP0938262A2 Nematicidal bacillus strain and metabolite and methods of use thereof
08/1999
08/31/1999US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent
08/31/1999US5945317 Isolated from fermentation cultures of nodulisporum species; for insecticides, nematocides, miticides
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 218